BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 1422569)

  • 1. Effects of cromakalim on the membrane potassium permeability of frog skeletal muscle in vitro.
    Benton DC; Haylett DG
    Br J Pharmacol; 1992 Sep; 107(1):152-5. PubMed ID: 1422569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder.
    Bonev AD; Nelson MT
    Am J Physiol; 1993 May; 264(5 Pt 1):C1190-200. PubMed ID: 8498480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K; Suzuki Y; Yoshida S; Nabata H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle.
    Trivedi S; Stetz S; Levin R; Li J; Kau S
    Pharmacology; 1994 Sep; 49(3):159-66. PubMed ID: 7972330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery.
    Bray K; Quast U
    Br J Pharmacol; 1991 Mar; 102(3):585-94. PubMed ID: 1285396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of Rb-permeable potassium channels to the relaxant and membrane hyperpolarizing actions of cromakalim, RP49356 and diazoxide in bovine tracheal smooth muscle.
    Longmore J; Bray KM; Weston AH
    Br J Pharmacol; 1991 Apr; 102(4):979-85. PubMed ID: 1855127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cromakalim and lemakalim on slow waves and membrane currents in colonic smooth muscle.
    Post JM; Stevens RJ; Sanders KM; Hume JR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C375-82. PubMed ID: 1996617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse effects of cromakalim on tension and 86Rb efflux in canine arterial smooth muscle.
    Masuzawa K; Matsuda T; Asano M
    Br J Pharmacol; 1991 May; 103(1):1033-40. PubMed ID: 1878743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of cetiedil and its congeners on levcromakalim-stimulated 86Rb efflux from smooth and skeletal muscle.
    Benton DC
    Eur J Pharmacol; 1996 Dec; 317(2-3):329-33. PubMed ID: 8997618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of potassium channel toxins from Leiurus quinquestriatus hebraeus venom on responses to cromakalim in rabbit blood vessels.
    Strong PN; Weir SW; Beech DJ; Hiestand P; Kocher HP
    Br J Pharmacol; 1989 Nov; 98(3):817-26. PubMed ID: 2531622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the K+ channel blocker tedisamil on 86Rb efflux induced by cromakalim, high potassium and noradrenaline, and on mechanical tension in rabbit isolated vascular smooth muscle.
    Kreye VA; Pfründer D; Theiss U
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):238-43. PubMed ID: 1570026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.
    Urquhart RA; Ford WR; Broadley KJ
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):279-88. PubMed ID: 7679163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ATP-sensitive K+ channels by cromakalim. Effects on cellular K+ loss and cardiac function in ischemic and reperfused mammalian ventricle.
    Venkatesh N; Stuart JS; Lamp ST; Alexander LD; Weiss JN
    Circ Res; 1992 Dec; 71(6):1324-33. PubMed ID: 1423930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
    Bray K; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):351-9. PubMed ID: 1961260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
    Lodge NJ; Halaka NN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices.
    Takata Y; Shimada F; Kato H
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1293-301. PubMed ID: 1469635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.